What Lavie bio does

Lavie Bio Ltd. was an Israeli agritech company headquartered in Rehovot that developed agricultural biologicals — specifically biostimulants and biopesticides — using beneficial bacteria formulations. The company's core offering centered on its patented MicroFermentor technology, a microbe formulation approach that enables bacteria to multiply directly on the plant, which the company claimed reduces application costs, extends shelf life, and improves post-application viability relative to conventional bioinoculant delivery. Lavie Bio leveraged the MicroBoost AI computational biology platform, developed by parent company Evogene, to identify microbial candidates and predict product performance, allowing the company to position itself at the intersection of synthetic biology and AI-driven screening.

Lavie Bio was founded in 2019 as a subsidiary of Evogene Ltd. with $27 million in initial capital, later raising $10 million from ICL Planet Startup Hub in 2022 and receiving a non-dilutive Israel Innovation Authority grant in September 2024 to advance MicroFermentor toward commercialization. The company employed between 11 and 50 people and served a single vertical — farmers and agricultural operations — though no specific customer logos, pricing models, or distribution channels were publicly disclosed, suggesting the business remained in a pre-commercial or pilot stage throughout its independent existence.

In 2025, Lavie Bio's activity was acquired by ICL Group Ltd., a specialty chemicals manufacturer pursuing strategic expansion into agricultural biologicals, through a divestiture by Evogene that was part of Evogene's broader shift to focus on its ChemPass AI platform. Evogene subsequently reported discontinuing the Lavie Bio subsidiary in Q1 2026, indicating the standalone entity was wound down and its assets and capabilities integrated into ICL's ag-biologicals business. Lavie Bio operated as a private, Israel-domiciled limited company throughout its existence with no public listing.

Name

Lavie bio

Legal name

Lavie Bio Ltd.

Website

https://lavie-bio.com

Company type

Private

Founded year

2019

Operating status

Acquired

Headcount range

11–50 employees

Short description

Lavie Bio was an Israeli agritech company developing agricultural biologicals — biostimulants and biopesticides — using its patented MicroFermentor bacteria technology and Evogene's MicroBoost AI platform. Founded in 2019, it served farmers seeking sustainable crop solutions before its 2025 acquisition by ICL Group and subsequent discontinuation as a standalone entity.

Ownership category

akta.pro rank

Product category

Agricultural Biologicals

NAICS

Pesticide and Other Agricultural Chemical Manufacturing (32532), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK)

akta.pro secondary industry

Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)

Keywords

• Agricultural biologicals
• Microbial biostimulants
• Biopesticide solutions
• Beneficial bacteria
• Crop enhancement

Headquarters

HQ city

Rehovot

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Core offering

Lavie Bio develops and produces agricultural biological products based on proprietary microbial formulations, led by its patented MicroFermentor technology that uses beneficial bacteria to enhance crop growth. The bacteria are formulated to multiply directly on plants, reducing application costs, extending shelf life, and improving viability after field application. The company leverages AI-powered computational biology platforms (MicroBoost AI) for microbial candidate identification and biostimulant and biopesticide development.

Product overview

Lavie Bio was an Israeli agritech company that developed biological products for sustainable agriculture, utilizing proprietary beneficial bacteria formulations. The company's primary offerings included MicroFermentor technology for microbe-based crop solutions. Lavie Bio operated as a subsidiary of Evogene, deploying its MicroBoost AI platform for product development in agricultural biologicals. In 2025, Lavie Bio's activity was acquired by ICL Group Ltd., and subsequently discontinued by Evogene as part of its strategic restructuring.

Differentiator

Problem solved

Functional benefit

Brands

• MicroBoost AI: AI computational biology platform used by Lavie Bio for developing microbial solutions in agriculture.
• MicroFermentor

Products and services

• MicroFermentor

Quantifiable outcome

• Reduces application costs through direct bacterial multiplication on plants
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves8 records

Expansion highlights3 records

Direct peers

• AgBiome: US-based developer of microbial crop protection products (biopesticides and biostimulants). Direct peer with similar proprietary microbe collection, formulation focus, and biologicals commercialization model.
• Indigo Ag: Largest US ag-biologicals player using microbial seed coatings and foliar products. Direct competitor in microbial biostimulants and biopesticides with comparable go-to-market via row crop and specialty crop growers.
• Pivot Bio: US-based ag-biological company developing microbial nitrogen-fixing products for major row crops. Directly comparable to Lavie Bio in microbial mode-of-action, AI-assisted discovery, and commercial focus on biostimulant-class agricultural biologicals.
• Sound Agriculture: US-based company developing on-demand microbial nitrogen and biostimulant products for row crops. Comparable microbial ag-biologicals positioning with overlapping grower customer profiles.
• NewLeaf Symbiotics: US ag-biological company commercializing pink-pigmented facultative methylotrophs (PPFMs) as biostimulants. Direct peer in microbial biostimulant category with overlapping row-crop and specialty-crop customer base.

Broad incumbents

• Koch Agronomic Services: Diversified specialty ag-inputs business with biologicals offerings alongside traditional fertilizers and micronutrients. Comparable adjacency to Lavie Bio's agricultural biologicals category with established global distribution.
• Marrone Bio Innovations (Bioceres Crop Solutions): Bioceres-affiliated biologicals platform with established biopesticide and biostimulant products. Comparable in end-product category and go-to-market, broader portfolio and global scale.
• Ginkgo Bioworks: US-listed synthetic biology platform with agricultural biologicals as a major vertical (formerly through Joyn Bio with Bayer). Comparable AI + microbial discovery model applied to ag inputs at much larger scale.

Emerging players

• Biotalys: Belgium-based ag-biological company developing protein-based biocontrol solutions. Comparable in agricultural biologicals category targeting crop protection, though using a different (protein-based) technological approach.
• BioConsortia: US-based ag-biological company using microbial consortia for nitrogen fixation, biocontrol, and biostimulants. Comparable technology stack and target applications, slightly earlier stage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/lavie-bio

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lavie bio